Literature DB >> 25410858

Identification of the physiological gene targets of the essential lytic replicative Kaposi's sarcoma-associated herpesvirus ORF57 protein.

Dinesh Verma1, Da-Jiang Li1, Brian Krueger2, Rolf Renne2, Sankar Swaminathan3.   

Abstract

UNLABELLED: The Kaposi's sarcoma-associated herpesvirus (KSHV) ORF57 gene product is essential for lytic KSHV replication and virion production. Recombinant ORF57-null mutants fail to accumulate several lytic cycle mRNAs at wild-type levels, leading to decreased production of lytic proteins necessary for efficient replication. Several mechanisms by which ORF57 may enhance expression of lytic KSHV mRNAs have been proposed, including mRNA stabilization, mRNA nuclear export, increased polyadenylation, and transcriptional activation. ORF57 activity is also gene specific, with some genes being highly dependent on ORF57, whereas others are relatively independent. Most experiments have utilized transfection models for ORF57 and have not systematically examined the gene specificity and potential mechanisms of action of ORF57 in the context of KSHV-infected cells. In this study, the KSHV genes that are most highly upregulated by ORF57 during KSHV lytic replication were identified by a combination of high-throughput deep RNA sequencing, quantitative PCR, Northern blotting, and rapid amplification of cDNA ends methods. Comparison of gene expression from a ΔORF57 KSHV recombinant, a rescued ΔORF57 KSHV recombinant, and wild-type KSHV revealed that two clusters of lytic genes are most highly dependent on ORF57 for efficient expression. Despite contiguous location in the genome and shared polyadenylation of several of the ORF57-dependent genes, ORF57 regulation was promoter and polyadenylation signal independent, suggesting that the mRNAs are stabilized by ORF57. The eight genes identified to critically require ORF57 belong to both early and late lytic temporal classes, and seven are involved in DNA replication, virion assembly, or viral infectivity, explaining the essential role of ORF57 in infectious KSHV production. IMPORTANCE: Kaposi's sarcoma-associated herpesvirus (KSHV) is a human herpesvirus involved in the causation of several human cancers. The KSHV ORF57 protein is required for KSHV to replicate and produce infectious virus. We have identified several KSHV genes whose expression is highly dependent on ORF57 and shown that ORF57 increases expression of these genes specifically. These genes code for proteins that are required for the virus to replicate its DNA and to infect other cells. Identifying the targets and mechanism of action of ORF57 provides further approaches to discover antiviral therapy.
Copyright © 2015, American Society for Microbiology. All Rights Reserved.

Entities:  

Mesh:

Substances:

Year:  2014        PMID: 25410858      PMCID: PMC4300733          DOI: 10.1128/JVI.02663-14

Source DB:  PubMed          Journal:  J Virol        ISSN: 0022-538X            Impact factor:   5.103


  48 in total

1.  Complement regulation by Kaposi's sarcoma-associated herpesvirus ORF4 protein.

Authors:  O Brad Spiller; Mairi Robinson; Elizabeth O'Donnell; Steven Milligan; B Paul Morgan; Andrew J Davison; David J Blackbourn
Journal:  J Virol       Date:  2003-01       Impact factor: 5.103

2.  Viral factors reveal a role for REF/Aly in nuclear RNA stability.

Authors:  Sarah H Stubbs; Olga V Hunter; Ashley Hoover; Nicholas K Conrad
Journal:  Mol Cell Biol       Date:  2012-01-30       Impact factor: 4.272

3.  The human herpesvirus 8 homolog of Epstein-Barr virus SM protein (KS-SM) is a posttranscriptional activator of gene expression.

Authors:  A K Gupta; V Ruvolo; C Patterson; S Swaminathan
Journal:  J Virol       Date:  2000-01       Impact factor: 5.103

4.  Nucleotide sequence of the Kaposi sarcoma-associated herpesvirus (HHV8).

Authors:  J J Russo; R A Bohenzky; M C Chien; J Chen; M Yan; D Maddalena; J P Parry; D Peruzzi; I S Edelman; Y Chang; P S Moore
Journal:  Proc Natl Acad Sci U S A       Date:  1996-12-10       Impact factor: 11.205

5.  Kaposi's sarcoma-associated herpesvirus open reading frame 57 encodes a posttranscriptional regulator with multiple distinct activities.

Authors:  J R Kirshner; D M Lukac; J Chang; D Ganem
Journal:  J Virol       Date:  2000-04       Impact factor: 5.103

6.  Epstein-Barr virus mRNA export factor EB2 is essential for production of infectious virus.

Authors:  Henri Gruffat; Julien Batisse; Dagmar Pich; Bernhard Neuhierl; Evelyne Manet; Wolfgang Hammerschmidt; Alain Sergeant
Journal:  J Virol       Date:  2002-10       Impact factor: 5.103

7.  Functional co-operation between the Kaposi's sarcoma-associated herpesvirus ORF57 and ORF50 regulatory proteins.

Authors:  Poonam Malik; David J Blackbourn; Ming Fei Cheng; Gary S Hayward; J Barklie Clements
Journal:  J Gen Virol       Date:  2004-08       Impact factor: 3.891

8.  The evolutionarily conserved Kaposi's sarcoma-associated herpesvirus ORF57 protein interacts with REF protein and acts as an RNA export factor.

Authors:  Poonam Malik; David J Blackbourn; J Barklie Clements
Journal:  J Biol Chem       Date:  2004-05-20       Impact factor: 5.157

9.  Herpes simplex virus type 1 ICP27 is an essential regulatory protein.

Authors:  W R Sacks; C C Greene; D P Aschman; P A Schaffer
Journal:  J Virol       Date:  1985-09       Impact factor: 5.103

10.  Requirement of varicella-zoster virus immediate-early 4 protein for viral replication.

Authors:  Bunji Sato; Marvin Sommer; Hideki Ito; Ann M Arvin
Journal:  J Virol       Date:  2003-11       Impact factor: 5.103

View more
  20 in total

1.  Identification and Characterization of the Physiological Gene Targets of the Essential Lytic Replicative Epstein-Barr Virus SM Protein.

Authors:  Jacob Thompson; Dinesh Verma; DaJiang Li; Tim Mosbruger; Sankar Swaminathan
Journal:  J Virol       Date:  2015-11-11       Impact factor: 5.103

Review 2.  New insights into the expression and functions of the Kaposi's sarcoma-associated herpesvirus long noncoding PAN RNA.

Authors:  Nicholas K Conrad
Journal:  Virus Res       Date:  2015-06-21       Impact factor: 3.303

3.  CRISPR/Cas9-Mediated Knockout and In Situ Inversion of the ORF57 Gene from All Copies of the Kaposi's Sarcoma-Associated Herpesvirus Genome in BCBL-1 Cells.

Authors:  Andrew BeltCappellino; Vladimir Majerciak; Alexei Lobanov; Justin Lack; Maggie Cam; Zhi-Ming Zheng
Journal:  J Virol       Date:  2019-10-15       Impact factor: 5.103

4.  Efficient Translation of Epstein-Barr Virus (EBV) DNA Polymerase Contributes to the Enhanced Lytic Replication Phenotype of M81 EBV.

Authors:  Trenton Mel Church; Dinesh Verma; Jacob Thompson; Sankar Swaminathan
Journal:  J Virol       Date:  2018-02-26       Impact factor: 5.103

5.  Protein-RNA Interactome Analysis Reveals Wide Association of Kaposi's Sarcoma-Associated Herpesvirus ORF57 with Host Noncoding RNAs and Polysomes.

Authors:  Beatriz Alvarado-Hernandez; Yanping Ma; Nishi R Sharma; Vladimir Majerciak; Alexei Lobanov; Maggie Cam; Jun Zhu; Zhi-Ming Zheng
Journal:  J Virol       Date:  2021-11-17       Impact factor: 6.549

Review 6.  Modulation of the Translational Landscape During Herpesvirus Infection.

Authors:  Britt A Glaunsinger
Journal:  Annu Rev Virol       Date:  2015-07-02       Impact factor: 10.431

7.  Alternative RNA splicing of KSHV ORF57 produces two different RNA isoforms.

Authors:  Vladimir Majerciak; Zhi-Ming Zheng
Journal:  Virology       Date:  2015-11-21       Impact factor: 3.616

8.  Complex Interactions between Cohesin and CTCF in Regulation of Kaposi's Sarcoma-Associated Herpesvirus Lytic Transcription.

Authors:  Dajiang Li; Tim Mosbruger; Dinesh Verma; Sankar Swaminathan
Journal:  J Virol       Date:  2020-01-06       Impact factor: 5.103

9.  Transcriptional and post-transcriptional regulation of viral gene expression in the gamma-herpesvirus Kaposi's sarcoma-associated herpesvirus.

Authors:  Matthew Butnaru; Marta M Gaglia
Journal:  Curr Clin Microbiol Rep       Date:  2018-08-03

Review 10.  Let It Go: HIV-1 cis-Acting Repressive Sequences.

Authors:  Philipp Niklas Ostermann; Anastasia Ritchie; Johannes Ptok; Heiner Schaal
Journal:  J Virol       Date:  2021-07-12       Impact factor: 5.103

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.